Laurus Labs Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for LAURUSLABS, BSE:540222 Laurus Labs Ltd.

Laurus Labs Ltd.

03 Dec 2016

589.95

-1.19%

Laurus Labs is a Hyderabad based company engaged in manufacturing of Active Pharma Ingredients (API). Company derives 80% of its revenues from exports while rest comes from the domestic markets. Its client base features companies like Cipla, Natco, Mylan, etc. API is its largest segment which contributes 92% of the revenues while rest 8% ..

Neutral: Laurus Labs Ltd.

Angel Broking

Laurus Labs is a Hyderabad based company engaged in manufacturing of Active Pharma Ingredients (API). Company derives 80% of its revenues from exports while rest comes from the domestic markets. Its client base features companies like Cipla, Natco, Mylan, etc. API is its largest segment which contributes 92% of the revenues while rest 8% comes from its Synthesis and Ingredients business. Investment rationale 1) Company operates its API business model with a niche focus on select therapeutic segments. This makes it a specialist API manufacturer in a few therapeutic segments. 2) Laurus intends to enter in the US market with its...

Laurus Labs Ltd. has gained 30.12% in the last 1 Year

Laurus Labs Ltd.

02 Dec 2016

589.95

-1.19%

Laurus Labs - IPO

Laurus Labs Ltd.

ICICI Securities Limited

The offer comprises a fresh issue (| 300 crore) and offer for sale. Net Laurus Labs (Laurus) is a leading Indian active pharma ingredient (API) manufacturer having a leadership position in the therapeutic areas of antiretrovirals (ARVs or anti-AIDS) and Hepatitis C. Laurus also manufactures APIs for oncology and other therapeutic areas. In FY16, nine out of the 10 largest generic pharmaceutical companies in the world (by revenues) were its customers. In FY16, it sold APIs in 32 countries. Laurus also has synthesis and neutraceutical/cosmeceuticals ingredients businesses. The company is planning to foray into the formulation segment. Till date, the...

Laurus Labs Ltd. has gained 20.61% in the last 6 Months

Is Laurus Labs Ltd. worth buying?

1220 Votes:

Buy 79.59%

Sell 10.82%

Hold 9.59%

RESEARCH REPORTS

Accumulate SEE REPORTS >

pdf

Hold SEE REPORTS >

pdf